Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4-Â and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical Trial
Keywords: biolimus; carrier-free; coronary artery disease; drug-coated stent(s); percutaneous coronary intervention; polymer-free; BFD; BioFreedom; DCS; drug-coated stent(s); DES; drug-eluting stent(s); FU; follow-up; LD; “low dose”; LLL; late lumen loss; NIH;